182 related articles for article (PubMed ID: 8213259)
21. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
[TBL] [Abstract][Full Text] [Related]
22. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene.
Malkoski SP; Dorin RI
Mol Endocrinol; 1999 Oct; 13(10):1629-44. PubMed ID: 10517666
[TBL] [Abstract][Full Text] [Related]
23. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene.
Meyer T; Carlstedt-Duke J; Starr DB
J Biol Chem; 1997 Dec; 272(49):30709-14. PubMed ID: 9388207
[TBL] [Abstract][Full Text] [Related]
24. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.
Sneddon WB; Bogado CE; Kiernan MS; Demay MB
Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768
[TBL] [Abstract][Full Text] [Related]
25. Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression.
Bortell R; Owen TA; Bidwell JP; Gavazzo P; Breen E; van Wijnen AJ; DeLuca HF; Stein JL; Lian JB; Stein GS
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):6119-23. PubMed ID: 1321435
[TBL] [Abstract][Full Text] [Related]
26. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice.
Kesterson RA; Stanley L; DeMayo F; Finegold M; Pike JW
Mol Endocrinol; 1993 Mar; 7(3):462-7. PubMed ID: 8483481
[TBL] [Abstract][Full Text] [Related]
27. Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.
Owen TA; Bortell R; Yocum SA; Smock SL; Zhang M; Abate C; Shalhoub V; Aronin N; Wright KL; van Wijnen AJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9990-4. PubMed ID: 2124710
[TBL] [Abstract][Full Text] [Related]
28. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
29. The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation.
Strömstedt PE; Poellinger L; Gustafsson JA; Carlstedt-Duke J
Mol Cell Biol; 1991 Jun; 11(6):3379-83. PubMed ID: 2038339
[TBL] [Abstract][Full Text] [Related]
30. Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements.
Bortell R; Owen TA; Shalhoub V; Heinrichs A; Aronow MA; Rochette-Egly C; Lutz Y; Stein JL; Lian JB; Stein GS
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2300-4. PubMed ID: 8460137
[TBL] [Abstract][Full Text] [Related]
31. A thyroid hormone receptor-dependent glucocorticoid induction.
Leers J; Steiner C; Renkawitz R; Muller M
Mol Endocrinol; 1994 Apr; 8(4):440-7. PubMed ID: 8052265
[TBL] [Abstract][Full Text] [Related]
32. On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.
Ray A; LaForge KS; Sehgal PB
Mol Cell Biol; 1990 Nov; 10(11):5736-46. PubMed ID: 2233715
[TBL] [Abstract][Full Text] [Related]
33. Glucocorticoids inhibit osteocalcin transcription in osteoblasts by suppressing Egr2/Krox20-binding enhancer.
Leclerc N; Noh T; Khokhar A; Smith E; Frenkel B
Arthritis Rheum; 2005 Mar; 52(3):929-39. PubMed ID: 15751078
[TBL] [Abstract][Full Text] [Related]
34. Extreme position dependence of a canonical hormone response element.
Nordeen SK; Ogden CA; Taraseviciene L; Lieberman BA
Mol Endocrinol; 1998 Jun; 12(6):891-8. PubMed ID: 9626664
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of gene expression by steroid hormone receptors via a negative glucocorticoid response element: evidence for the involvement of DNA-binding and agonistic effects of the antiglucocorticoid/antiprogestin RU486.
Cairns C; Cairns W; Okret S
DNA Cell Biol; 1993 Oct; 12(8):695-702. PubMed ID: 8397827
[TBL] [Abstract][Full Text] [Related]
36. Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis.
Ohnaka K; Taniguchi H; Kawate H; Nawata H; Takayanagi R
Biochem Biophys Res Commun; 2004 May; 318(1):259-64. PubMed ID: 15110782
[TBL] [Abstract][Full Text] [Related]
37. A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1beta gene.
Zhang G; Zhang L; Duff GW
DNA Cell Biol; 1997 Feb; 16(2):145-52. PubMed ID: 9052735
[TBL] [Abstract][Full Text] [Related]
38. Differential gene induction by glucocorticoid and progesterone receptors.
Thackray VG; Lieberman BA; Nordeen SK
J Steroid Biochem Mol Biol; 1998 Aug; 66(4):171-8. PubMed ID: 9744514
[TBL] [Abstract][Full Text] [Related]
39. The rat glucocorticoid receptor mutant K461A differentiates between two different mechanisms of transrepression.
Meyer T; Starr DB; Carlstedt-Duke J
J Biol Chem; 1997 Aug; 272(34):21090-5. PubMed ID: 9261112
[TBL] [Abstract][Full Text] [Related]
40. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene.
Drouin J; Sun YL; Chamberland M; Gauthier Y; De Léan A; Nemer M; Schmidt TJ
EMBO J; 1993 Jan; 12(1):145-56. PubMed ID: 8428574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
